Suzanne Bruhn

About Suzanne Bruhn

Experienced leader with a passion for patient-focused drug development. Committed to patient advocacy and community support, with a track record of success in the development, commercialization, and partnering of products for the treatment of serious diseases with significant unmet need. In-depth knowledge of the rare disease and neuroscience space through both executive leadership and Board of Director roles in high growth public and private companies. Deep understanding of business development, corporate strategy, and global Regulatory Affairs. Adaptable leadership style honed through significant experience in corporate transition, growth, globalization, team building, and change management.

Experience

1. Board Member

   Travere Therapeutics

   Apr 2020 — Present · San Diego, CA, US

   Independent Director at Travere Therapeutics (NASDAQ: TVTX), a commercial biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. Member: Compensation and Science and Technology committees

Education

• Harvard Medical School

  Postdoctoral Fellow, Cell Biology

• Massachusetts Institute of Technology

  PhD, Chemistry

• Iowa State University

  Bachelor of Science, Chemistry